Pharma & Biotech

Deciphera Pharmaceuticals has achieved a pivotal regulatory victory with the European Commission granting marketing authorization for its drug ROMVIMZA™. The...

A routine tax-related transaction by a senior executive created downward pressure on Apellis Pharmaceuticals shares this week. Despite the stock...

The biotechnology landscape witnessed a significant consolidation in the second quarter of 2024 as Vertex Pharmaceuticals Incorporated finalized its acquisition...

The medical technology firm CONMED has appointed a new director to its board, bringing in seasoned industry executive Kim Kelderman,...

Biopharmaceutical company Alx Oncology Holdings has successfully navigated a critical challenge to its exchange listing, though this achievement coincides with...

Recent SEC filings have revealed a significant development for biotechnology firm Design Therapeutics: investment management company Acadian Asset Management now...

Iovance Biotherapeutics is confronting a severe equity downturn, with its stock value declining by 69% since the start of the...

Rallybio's stock continues to exhibit significant price swings despite recent gains, with technical indicators and trading patterns presenting a complex...

The biotechnology firm Ardelyx approaches a definitive moment in its corporate history. A court ruling scheduled for September 25th will...

French biotechnology firm Valneva has encountered a severe regulatory obstacle following the US Food and Drug Administration's (FDA) immediate suspension...